Back

Impact of coronary revascularisation on left ventricular remodelling in ischaemic cardiomyopathy with reduced ejection fraction

28 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: focus on remodelling Heart Failure with Reduced Ejection Fraction (HFrEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Bahram Kadyrov

International Cardiology Centre, Ashgabat (Turkmenistan)

7 More presentations in this session

Presentation thumbnail
Monocyte F2RL1 signaling defines an adverse remodeling phenotype in heart failure
Ms E. Ghanbari (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Cardiac function and the effect of heart failure treatment in patients with genotype-positive dilated cardiomyopathy
Doctor P. Olsen (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Importance and significance of left atrial reverse remodelling in the follow-up of patients with heart failure
Miss L. Silva (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Early post-surgery left ventricular changes helps to identify patients with residual valvular cardiomyopathy in primary valvular regurgitation
Doctor Y. Kang (Chengdu, CN)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of CMR-derived indexed left ventricular end-diastolic volume (LVEDVi) in individuals with preserved and reduced LV ejection fraction - a UK Biobank study
Doctor P. Van Rijckeghem (Aachen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: focus on remodelling

The Event

Event poster

ESC Congress 2026

28 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of coronary revascularisation in patients undergoing cardiovascular magnetic resonance for viability assessment
29 August 2025
thumbnail
Congress Presentation
Improvement of functional capacity in patients with heart failure and improved ejection fraction.
31 August 2025
thumbnail
Congress Presentation
Reverse cardiac remodeling following with sacubitril/valsartan in heart failure: comparison between ischemic and non-ischemic etiology
29 August 2025
thumbnail
Congress Presentation
Real-world outcomes and predictors of LV reverse remodelling after successful CTO PCI in HFrEF: insights from a multicentre registry
10 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources